Home Newsfeeds ‘Volcon On Track To Release First Electric Bicycle Soon’ -InsideEVs Report

News

‘Volcon On Track To Release First Electric Bicycle Soon’ -InsideEVs Report

https://insideevs.com/news/606967/volocn-brat-teased-socia-media/amp/

byBenzinga Newsdesk

August 29, 2022

1 minute read

https://insideevs.com/news/606967/volocn-brat-teased-socia-media/amp/

Biote Names Robert Peterson As Chief Financial Officer, Effective January 8, 2024

By Benzinga Newsdesk

January 11, 5:12 PM

biote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that Robert

BTMD

Ranger Energy Services Expects FY23 Revenue of $630M-$640M (Prior $660M-$680M) Vs. $655.35M Est

By Benzinga Newsdesk

October 31, 6:53 AM

In light of lower than expected customer activity, the Company is updating its financial expectations for the year. The Company does see signals of an improving North America onshore environment from currently depressed

RNGR

News

Beyond Cancer Reports Phase 1a Data on Nitric Oxide Treatment for Solid Tumors at ASCO 2024

By Benzinga Newsdesk

June 3, 7:12 AM

Beyond Cancer, Ltd., a clinical-stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors, announced encouraging first-in-class clinical data

XAIR

News

Surgalign Announces Third Clinical Site In The Commercialization And Performs First Case Of Its HOLO Portal Surgical Guidance System

By Benzinga Newsdesk

September 15, 8:49 AM

DEERFIELD, Ill., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ:SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today

SRGA

‘Volcon On Track To Release First Electric Bicycle Soon’ -InsideEVs Report

Related Posts

Biote Names Robert Peterson As Chief Financial Officer, Effective January 8, 2024

Ranger Energy Services Expects FY23 Revenue of $630M-$640M (Prior $660M-$680M) Vs. $655.35M Est

Beyond Cancer Reports Phase 1a Data on Nitric Oxide Treatment for Solid Tumors at ASCO 2024

Surgalign Announces Third Clinical Site In The Commercialization And Performs First Case Of Its HOLO Portal Surgical Guidance System